Trial Profile
A phase II trial of neoadjuvant imatinib for large gastric GIST in Japan and Korea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 28 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network- Japan record.
- 18 Dec 2013 Primary endpoint is changed from progression free survival to complete resection rate as per University Hospital Medical Information Network- Japan record.
- 17 Dec 2013 Planned number of patients changed from 40 to 55 as reported by University Hospital Medical Information Network- Japan record.